ArticleBiomedicines2025
Correction: Al-Lahham et al. Reference Interval for Glycated Albumin, 1,5-AG/GA, and GA/HbA1c Ratios and Cut-Off Values for Type 1, Type 2, and Gestational Diabetes: A Cross-Sectional Study.
Yusra Al-Lahham, Waldemar Volanski, Liana Signorini, Ademir Luiz do Prado, Glaucio Valdameri, Vivian Rotuno Moure, Marciane Welter, Alexessander C Alves, Marcel Henrique Marcondes Sari, Fabiane Gomes de Moraes Rego and 1 more
Abstract readPublished Erratum
In one paragraphArticle in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
11 authors.
Yusra Al-LahhamGraduate Program in Pharmaceutical Sciences, Federal University of Paraná, Curitiba 80210-170, Brazil.ORCID 0000-0002-0506-1852 Waldemar VolanskiGraduate Program in Pharmaceutical Sciences, Federal University of Paraná, Curitiba 80210-170, Brazil.
Liana SignoriniGraduate Program in Pharmaceutical Sciences, Federal University of Paraná, Curitiba 80210-170, Brazil.
Ademir Luiz do PradoGraduate Program in Pharmaceutical Sciences, Federal University of Paraná, Curitiba 80210-170, Brazil.ORCID 0000-0002-9914-3831 Glaucio ValdameriGraduate Program in Pharmaceutical Sciences, Federal University of Paraná, Curitiba 80210-170, Brazil.ORCID 0000-0003-1882-1512 Vivian Rotuno MoureGraduate Program in Pharmaceutical Sciences, Federal University of Paraná, Curitiba 80210-170, Brazil.ORCID 0000-0003-0968-8190 Marciane WelterGraduate Program in Pharmaceutical Sciences, Federal University of Paraná, Curitiba 80210-170, Brazil.
Alexessander C AlvesSchool of Human Development and Health, Faculty of Medicine, University of Southampton, Southampton SO17 1BJ, UK.ORCID 0000-0001-8519-7356 Marcel Henrique Marcondes SariGraduate Program in Pharmaceutical Sciences, Federal University of Paraná, Curitiba 80210-170, Brazil.ORCID 0000-0002-9913-9306 Fabiane Gomes de Moraes RegoGraduate Program in Pharmaceutical Sciences, Federal University of Paraná, Curitiba 80210-170, Brazil.ORCID 0000-0003-1726-8524 Geraldo PichethGraduate Program in Pharmaceutical Sciences, Federal University of Paraná, Curitiba 80210-170, Brazil.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
In the original publication [...].
Identifiers
PMID40679499
PMCPMC12273805
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390